✦ LIBER ✦

Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study

✍ Scribed by Franco M. Muggia; John A. Blessing; Steven Waggoner; Jonathan S. Berek; Bradley J. Monk; Joel Sorosky; Michael L. Pearl

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of tamoxifen in persistent or

✍ L. R. Bigler; J. Tate Thigpen; J. A. Blessing; J. Fiorica; B. J. Monk 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Evaluation of vinorelbine in persistent

✍ Franco M Muggia; John A Blessing; Michael Method; David Scott Miller; Gary A Joh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Phase II trial of cetuximab in the treat

✍ A. Santin; G. Patricia; M. Sill; D. McMeekin; M. Leitao; J. Brown; G. Sutton; L. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase II evaluation of capecitabine in r

✍ K.Y. LOOK; J.A. BLESSING; C.M. MICHENER; S.C. RUBIN; P.T. RAMIREZ 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Phase II Study of Ifosfamide and Mesna i

✍ Gregory P. Sutton; John A. Blessing; Philip J. DiSaia; William P. McGuire 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A randomized phase II evaluation of bryo

✍ Deborah K. Armstrong; John A. Blessing; Janet Rader; Joel I. Sorosky 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 63 KB